The cannabinoid system and cytokine network (44546)

Experimental Biology and Medicine

Volumn 225, Issue 1, 2000, Pages 1-8

  Klein, Thomas W ^a   Lane, Brian ^a   Newton, Catherine A ^a   Friedman, Herman ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 ARACHIDONOYLGLYCEROL; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; 5 (4 CHLORO 3 METHYLPHENYL) 1 (4 METHYLBENZYL) N (1,3,3 TRIMETHYLBICYCLO[2.2.1]HEPTAN 2 YL) 3 PYRAZOLECARBOXAMIDE; AJULEMIC ACID; ANANDAMIDE; CANNABINOID RECEPTOR; CANNABINOID RECEPTOR AGONIST; CANNABINOID RECEPTOR ANTAGONIST; CANNABIS; CYTOKINE; DEXANABINOL; DMH 11C; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; ICOSANOID; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1; PALMIDROL; PROLACTIN; PSYCHOTROPIC AGENT; RANTES; RIMONABANT; TETRAHYDROCANNABINOL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTIINFLAMMATORY ACTIVITY; CELLULAR IMMUNITY; CHEMICAL STRUCTURE; CYTOKINE RELEASE; DRUG EFFECT; DRUG STRUCTURE; HUMAN; HUMORAL IMMUNITY; IMMUNOREGULATION; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; SHORT SURVEY;

EID: 0033803432     PISSN: 00379727     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1373.2000.22501.x     Document Type: Article

References (19)

1. Klein TW, Newton C, Zhu W, Daaka Y. Friedman H. Minireview: Δ9-tetrahydrocannabinol, cytokines, and immunity to Legionella pneumophila. Proc Soc Exp Biol Med 209:205-212, 1995.
2. Klein T, Newton C, Friedman H. Cannabinoid receptors and immunity. Immunol Today 19:373-381, 1998.
3. Klein T, Friedman H, Specter S. Marijuana immunity, and infection. J Neuroimmunol 83:102-115, 1998.
4. Felder C, Glass M. Cannabinoid receptors and their endogenous agonists. Annu Rev Pharmacol Toxicol 38:179-200, 1998.
5. Cabral G, Dove Pettit D. Drugs and immunity: Cannabinoids and their role in decreased resistance to infectious diseases'. J Neuroimmunol 83:116-123, 1998.
6. Howlett AC. Pharmacology of Cannabinoid receptors. Annu Rev Pharmacol Toxicol 35:607-634, 1995.
7. Matsuda LA, Lolait SJ. Brownstein MJ, Young AC, Bonner TI. Structure of Cannabinoid receptor and functional expression of the cloned cDNA. Nature 346:561-564, 1990.
8. Bernstein KE, Ali MS, Sayeski PP, Semeniuk D, Marrero MB. New insights into the cellular signaling of seven transmembrane receptors: The role of tyrosine phosphorylation. Lab Invest 78:3-7, 1998.
9. Ji TH, Grossmann M, Ji I. G protein-coupled receptors I. Diversity of receptor-ligand interactions. J Biol Chem 273:17299-17302, 1998.
10. Kenakin T. The classification of seven transmembrane receptors in recombinant expression systems. Pharmacol Rev 48:413-463, 1996.
11. Abood ME, Ditto KE, Noel MA, Showalter VM, Tao Q. Isolation and expression of a mouse CB1 Cannabinoid receptor gene: Comparison of binding properties with those of native CB1 receptors in mouse brain and N18TG2 neuroblastoma cells. Biochem Pharmacol 53:207-214, 1997.
12. Shire D, Calandra B, Delpech M, Dumont X, Kaghad M, Le Fur G, Caput D, Ferrara P_. Structural features of the central Cannabinoid CB1 receptor involved in the binding of the specific CB1 antagonist SR 141716A. J Biol Chem 271:6941-6946, 1996.
13. Song Z-H, Bonner TI. A lysine residue of the cannabinoid receptor is critical for receptor recognition by several agonists but not WIN55,212-2. Mol Pharmacol 49:891-896, 1996.
14. Tao Q, Abood ME. Mutation of a highly conserved aspartate residue in the second transmembrane domain of the cannabinoid receptors, CB1 and CB2, disrupts G-protein coupling. J Pharmacol Exp Ther 285:651-658, 1998.
15. Dove-Pettit DA, Harrison MP, Olson JM, Spencer RF, Cabrai GA. Immunochemical localization of the neural cannabinoid receptor in rat brain. J Neurosci Res 51:391-402, 1998.
16. Gerard CM, Mollereau C, Vassart G, Parmentier M. Molecular cloning of a human cannabinoid receptor which is also expressed in testis. Biochem J 279:129-134, 1991.
17. Kaminski NE, Abood ME, Kessler FK, Martin BR, Schatz AR. Identification of a functionally relevant cannabinoid receptor on mouse spleen cells that is involved in cannabinoid-mediated immune modulation. Mol Pharmacol 42:735-742, 1992.
18. Munro S, Thomas KL, Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature 365:61-65, 1993.
19. Shire D, Calandra B, Rinaldi-Carmona M, Oustric D, Pessegue B, Bonnin-Cabanne O, Le Fur G, Caput D, Ferrara P. Molecular cloning, expression, and function of the murine CB2 peripheral cannabinoid receptor. Biochim Biophys Acta 1307:132-136, 1996.